Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Tanner

Showing results (51-60 of 133) with videos related to

Pageof 14
Sort By:
Neurology|February 1, 1982
Primary writing tremor: a selective action tremorH L Klawans, R Glantz, C M Tanner, et al.
Archives of Neurology|December 1, 1983
Pergolide in Parkinson's diseaseC G Goetz, C M Tanner, R Glantz, et al.
Neurology|June 1, 1985
Pergolide mesylate: lack of cardiac toxicity in patients with cardiac diseaseC M Tanner, R Chhablani, C G Goetz, et al.
European Journal of Neurology|June 11, 2015
Head injury, α-synuclein Rep1 and Parkinson's disease: a meta-analytic view of gene-environment interactionS M Goldman, D M Umbach, F Kamel, et al.
Journal of the American Veterinary Medical Association|August 27, 2013
ECG of the Month. ArrhythmiaJacqueline C M Tanner, Geri A Lake-Bakaar, Mark D Kittleson
Advances in Neurology|January 1, 1983
A 6-month trial of pergolide mesylate in the treatment of idiopathic Parkinson's diseaseH L Klawans, C M Tanner, S Glatt, et al.
Neurology|July 1, 1992
Dysphagia after botulinum toxin injections for spasmodic torticollis: clinical and radiologic findingsC L Comella, C M Tanner, L DeFoor-Hill, et al.
The Journal of Clinical Psychiatry|April 1, 1985
The pathophysiology of tardive dyskinesiaH L Klawans, P Carvey, C M Tanner, et al.
Neurology|September 25, 1998
Early dopaminergic drug-induced hallucinations in parkinsonian patientsC G Goetz, C Vogel, C M Tanner, et al.
Life Sciences|April 9, 1984
Neuroleptic-induced dopamine hyposensitivityC G Goetz, P M Carvey, C M Tanner, et al.
Pageof 14

Showing results (51-60 of 133) with videos related to

Sort By:
Pageof 14
Neurology|February 1, 1982
Primary writing tremor: a selective action tremorH L Klawans, R Glantz, C M Tanner, et al.
Archives of Neurology|December 1, 1983
Pergolide in Parkinson's diseaseC G Goetz, C M Tanner, R Glantz, et al.
Neurology|June 1, 1985
Pergolide mesylate: lack of cardiac toxicity in patients with cardiac diseaseC M Tanner, R Chhablani, C G Goetz, et al.
European Journal of Neurology|June 11, 2015
Head injury, α-synuclein Rep1 and Parkinson's disease: a meta-analytic view of gene-environment interactionS M Goldman, D M Umbach, F Kamel, et al.
Journal of the American Veterinary Medical Association|August 27, 2013
ECG of the Month. ArrhythmiaJacqueline C M Tanner, Geri A Lake-Bakaar, Mark D Kittleson
Advances in Neurology|January 1, 1983
A 6-month trial of pergolide mesylate in the treatment of idiopathic Parkinson's diseaseH L Klawans, C M Tanner, S Glatt, et al.
Neurology|July 1, 1992
Dysphagia after botulinum toxin injections for spasmodic torticollis: clinical and radiologic findingsC L Comella, C M Tanner, L DeFoor-Hill, et al.
The Journal of Clinical Psychiatry|April 1, 1985
The pathophysiology of tardive dyskinesiaH L Klawans, P Carvey, C M Tanner, et al.
Neurology|September 25, 1998
Early dopaminergic drug-induced hallucinations in parkinsonian patientsC G Goetz, C Vogel, C M Tanner, et al.
Life Sciences|April 9, 1984
Neuroleptic-induced dopamine hyposensitivityC G Goetz, P M Carvey, C M Tanner, et al.
Pageof 14